Related Experiment Video
Updated: Jul 11, 2026
12:34
The Efficacy and Underlying Pathway Mechanisms of ShiDuGao Treatment for Anus Eczema Based on GEO Datasets and Network Pharmacology
Published on: January 12, 2024
Towards the Common Data Model for an Intensive Medicine Data Space in Europe.
Carlos Luis Parra-Calderón1, Celia Alvarez-Romero1, María González-López1
1Computational Health Informatics Group, Institute of Biomedicine of Seville, IBIS/ Virgen del Rocío University Hospital/CSIC/University of Seville, Spain.
Studies in Health Technology and Informatics
|May 17, 2025
Summary
This study identifies key research areas for a European Intensive Medicine Data Space. It focuses on standardizing Intensive Care Unit (ICU) data for better interoperability, data sharing, and innovation while ensuring data protection.
Area of Science:
- Health Informatics
- Data Science
- Medical Data Interoperability
Background:
- The need for a unified semantic interoperability framework in European Intensive Medicine.
- Challenges in standardizing diverse Intensive Care Unit (ICU) data sets.
Purpose of the Study:
- To identify Key Research Areas for building and deploying a semantic interoperability framework for the Intensive Medicine Data Space in Europe.
- To define challenges and requirements for data standardization, interoperability, and secondary use of ICU data.
Main Methods:
- Expert consensus on defining research areas and associated challenges.
- Focus on Common Data Models, vocabularies, and standardized data elements.
- Adherence to FAIR principles for data access and querying.
Main Results:
- Four key research areas were defined by European experts.
- Characterization of the value of standardized data for ICU data sets.
- Derivation of a Common Data Model for seamless data interoperability.
- Definition of data standardization processes for secondary use and decision support.
- Requirements for anonymization and pseudonymization balancing data protection and innovation.
Conclusions:
- Establishing a semantic interoperability framework is crucial for the Intensive Medicine Data Space.
- Standardization, interoperability, and secure data sharing are foundational for secondary use and innovation in intensive care.
- Balancing data protection with the need for data access is a key consideration.
Keywords:
Artificial IntelligenceClinical Decision SupportCommon Data ModelData SpaceIntensive CareInteroperabilityStandardizationVocabulariesMore Related Videos
Related Concept Videos
01:30Quantitative Aspects of Drug-Receptor Interaction
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
01:22Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
01:14Model Approaches for Pharmacokinetic Data: Compartment Models
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...